Summarize Experience, Check Problems, Formulate Measures, Fully Deploy 2022 Work
Release time:
2022-02-08
News from our newspaper # February 25 and 26 , the group company held a business work analysis meeting to review and summarize the work situation in 2021 , arrange and deploy the work for the new year, and put forward work requirements. At the
meeting, various professional companies and directly affiliated enterprises made a report on the overall work situation of 2021 , focusing on analyzing the existing problems and deficiencies, and proposing corresponding solutions and a work plan for 2021 . The functional departments and offices of the headquarters made a brief report on the annual work situation and the 2021 work plan. Xiang Chongping, deputy general manager of the group company, systematically combed the human resources development in 2021 from the current human resources structure, recruitment and resignation, training management, salary level and labor productivity, enterprise labor management, etc. Lan Xiaolong, head of finance, analyzed the company's profit and profit structure in 2021 , and pointed out the risk points that need attention in operation and management; chen Tianci, Chairman of the Board of Supervisors, analyzed the overall situation of technological transformation projects of various enterprises in the three years of 2019-2021 and the problems existing in the implementation process. Zhu Jianwei, secretary of the board of directors, analyzed the future risks that the company may encounter from the aspects of peak and listed companies in related industries in the year 2021 and the revision of listing rules. Yu Jianhong, general manager of
Group Company, made a comprehensive review of the company's operation in 2021 , made a comparative analysis of the main economic indicators of various industrial sectors, and pointed out that substantial progress has been made in the construction of key investment projects. Continue to strengthen management integration and effectively improve the management level; New achievements have been made in scientific and technological innovation and technological transformation. Overcoming the adverse effects of epidemic situation, power restriction and production restriction, efforts to expand sales; strengthen personnel training, selection and introduction, and optimize the salary system; to celebrate the centenary of the founding of the party and the study and education of party history as a starting point, strengthen party building and ideological and political construction, and enhance the cohesion and centripetal force of enterprises; strengthen the daily prevention and control of the new coronary pneumonia epidemic to ensure the safety and health of employees; and effectively enhance the corporate image, influence and reputation and other work highlights. In particular, the results of a series of technological transformation of Daye Peak are remarkable, many economic and technical indicators of Huang Ping Peak have reached the leading level in the industry, the market sales of Olopatadine Eye Drops, a new product of Peak Pharmaceutical, are progressing smoothly, and the legal work of the Office of the Board of Directors and the safety management measures of the Audit Performance Management Department are promoted. At the same time, it also focuses on some problems such as the decline in profit level, the slower-than-expected progress of new projects, the higher labor productivity of production lines, the insufficient innovation ability of research and development capability, the outdated ideas and thinking modes of management personnel, the unsatisfactory construction of talent team, and the rise of the phenomenon of "three violations " .
Based on the current macroeconomic situation and the future trends of various related industries, Yu Jianhong, on behalf of the Group, proposed the working policy of 2022 as "Reform, Breakthrough, Innovation, Development " , and around this policy, proposed the key work of 2022 , with emphasis, planning for the future development of "second curve " , breaking through the development bottleneck and quickly entering a new growth track is the company's current top priority. Under the company's existing system and mechanism, it is necessary to solve the three problems of development motivation, development concept and development ability, that is, to stimulate development motivation through cultural identity, value feelings and incentive evaluation. Advocate the development concept of "to be user-oriented, supported by technology, efficiency, value and mode leadership, and build a value chain or ecological circle " ; with excellent talents, efficient team and organizational structure to improve the enterprise to capture opportunities, operations integration, resource mining, risk identification and other development capabilities. It is hoped that management cadres at all levels will practice themselves, be strict with themselves, and vigorously advocate a truth-seeking and pragmatic work style. Management cadres will take the lead in telling the truth, doing practical things, seeking practical results, not engaging in formalism, and not making superficial articles; always maintain a spirit of forge ahead and never slack off The state of mind and the attitude of daring to break through and work, and resolutely put an end to the negative tendency of waiting, relying, relying, and demanding; vigorously advocate the work style of "to efficiency " , and resolutely put an end to the bad atmosphere of prevarication, discussion but not decision, and only saying but not doing. Vigorously advocate the work style of "raising enterprises as their own children " , put yourself in the position of seeking things, keep improving things, and strive to achieve perfection in every work; vigorously advocate "thrifty enterprise " work style, spend every penny on the blade, control every cost to the lowest, and improve the market competitiveness of enterprises and products. In his concluding speech, Jiang Xiaomeng, chairman of
Group Company, expressed his affirmation and gratitude to all enterprises for their efforts and achievements in 2021 , commented on their resource acquisition ability, team morale, internal system construction, employee centripetal force, etc., and hoped that all enterprise management teams would seriously reflect, efforts to improve the communication ability at work, the determination and responsibility of handling affairs, and be able to discover and solve problems with a more systematic thinking and a more comprehensive perspective. Jiang Xiaomeng pointed out that in the future work, "cost reduction " will always be the main tone and the most basic competitiveness for enterprises to participate in market competition. The intelligence and digitization of production enterprises for the purpose of improving labor productivity is the general trend, and we must speed up the in-depth development. Innovation work such as technological transformation and new drug research and development should be strengthened and accelerated; new investment projects need to spend more energy to accelerate. He emphasized that management teams at all levels must unify their thinking, clarify management relationships, and establish a sound system in order to better improve the team's combat effectiveness and work passion, and promote the better development of the enterprise. (Reporter Fu Yiwu)
More information
The company fully deploys 2018 work
On January 27, the group company held a business analysis meeting to review and summarize the work in 2017, arrange and deploy the work for the new year, and put forward work requirements. At the meeting, various professional companies and directly affiliated enterprises reported on the overall work situation in 2017, focusing on analyzing the existing problems and deficiencies, and proposing corresponding solutions and work plans for 2018. Xiang Chongping, deputy general manager of the group company, systematically combed the current human resources efficiency and human resources development of the company. Chen Tianci, chairman of the board of supervisors, made a report and analysis on the "three reductions and three improvements" and the safety and environmental protection work in 2017. Lan Xiaolong, head of finance, analyzed the risks and challenges currently faced by the company according to the operating data and financial situation of its subordinate enterprises. The functional departments and offices of the headquarters also made a brief report on their annual work. Yu Jianhong, general manager of the group company, made a comprehensive review of the company's operation in 2017, compared and analyzed the main economic indicators of various industrial sectors, and pointed out that looking for new investment and development projects around strategic objectives, promoting the optimization of organizational structure and post setting, significantly improving the level of information management, improving the ability of fund management and tax planning, achieving certain results in scientific and technological innovation and technological transformation, and strengthening marketing management and market expansion, safety and environmental protection work is basically up to standard, training and talent development have achieved new results and other work highlights; at the same time, it summarizes and reflects on the shortcomings in strategic decision-making, management innovation, performance appraisal, market operation, and talent team building. After analyzing the current macroeconomic situation and the future trends of various related industries, Yu Jianhong informed
2020
07-31
Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base
News from our newspaper On January 19, the group company held the second meeting of the tenth board of directors and reviewed and approved the "Proposal on Foreign Investment of Subsidiary Jianfeng Pharmaceutical." On the same day, Jianfeng Pharmaceutical signed an agreement to invest in Shanghai North Carolina Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Shanghai North Carolina") by acquiring shares and increasing capital. Shanghai Beika is a high-tech enterprise in Shanghai. It has an academician expert workstation and a number of Shanghai high-tech achievements transformation projects. It has won the title of "second prize for scientific and technological progress" in Songjiang District, Shanghai, "patent pilot enterprise" and "enterprise technology center" in Songjiang District, Shanghai. The company has strong research and development capabilities and has obtained 14 patents. At present, its main business is to provide products and customized services for domestic and foreign pharmaceutical companies. The products mainly include Tinib, alkaloids, carbohydrates and other anti-tumor drug intermediates. The customized services are mainly CDMO (contract development and manufacturing) of new drugs and intermediates. Shanghai North Carolina has two wholly-owned subsidiaries, Anhui Changtai Chemical Co., Ltd. (hereinafter referred to as "Changtai Chemical") and Anhui North Carolina Pharmaceutical Co., Ltd. (hereinafter referred to as "Anhui North Carolina"). Changtai Chemical is a pesticide manufacturer designated by the Ministry of Industry and Information Technology. It was established in July 2007. It now has three chemical synthesis workshops and a pesticide preparation compounding workshop, with 10 product approvals and 13 patents. Anhui North Carolina was established in December 2016. Its business scope includes the customization, production and sales of chemical raw materials and pharmaceutical intermediates, and the wholesale and retail of chemical raw materials and products (except hazardous chemicals
2020
07-30
Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base
News from our newspaper On January 19, the group company held the second meeting of the tenth board of directors and reviewed and approved the "Proposal on Foreign Investment of Subsidiary Jianfeng Pharmaceutical." On the same day, Jianfeng Pharmaceutical signed an agreement to invest in Shanghai North Carolina Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Shanghai North Carolina") by acquiring shares and increasing capital. Shanghai Beika is a high-tech enterprise in Shanghai. It has an academician expert workstation and a number of Shanghai high-tech achievements transformation projects. It has won the title of "second prize for scientific and technological progress" in Songjiang District, Shanghai, "patent pilot enterprise" and "enterprise technology center" in Songjiang District, Shanghai. The company has strong research and development capabilities and has obtained 14 patents. At present, its main business is to provide products and customized services for domestic and foreign pharmaceutical companies. The products mainly include Tinib, alkaloids, carbohydrates and other anti-tumor drug intermediates. The customized services are mainly CDMO (contract development and manufacturing) of new drugs and intermediates. Shanghai North Carolina has two wholly-owned subsidiaries, Anhui Changtai Chemical Co., Ltd. (hereinafter referred to as "Changtai Chemical") and Anhui North Carolina Pharmaceutical Co., Ltd. (hereinafter referred to as "Anhui North Carolina"). Changtai Chemical is a pesticide manufacturer designated by the Ministry of Industry and Information Technology. It was established in July 2007. It now has three chemical synthesis workshops and a pesticide preparation compounding workshop, with 10 product approvals and 13 patents. Anhui North Carolina was established in December 2016. Its business scope includes the customization, production and sales of chemical raw materials and pharmaceutical intermediates, and the wholesale and retail of chemical raw materials and products (except hazardous chemicals
2020
07-31
Jianfeng Pharmaceutical was rated as a provincial trademark brand demonstration enterprise
On December 28, 2017, Zhejiang Administration for Industry and Commerce announced the list of trademark brand demonstration counties (cities, districts), demonstration towns (streets) and demonstration enterprises in Zhejiang Province in 2017. Jianfeng Pharmaceutical Company was identified as a trademark brand demonstration enterprise, and it was also the only enterprise in Jinhua City to enter the list. Peak Pharmaceutical was established in 1998 and obtained the first registered trademark in 1999. Since then, Jianfeng Pharmaceutical has been actively carrying out brand building in accordance with the requirements of the Trademark Law and other laws and regulations, and has set up an intellectual property department to carry out trademark management, rights protection and other activities; it has established a sound trademark management system, strictly in accordance with the provisions of the Trademark Law to supervise and manage the use of trademarks inside and outside the enterprise, and safeguard the legitimate rights and interests of the enterprise. Establish strategic cooperation with professional institutions, for trademark applications, renewals and other work. In recent years, Jianfeng Pharmaceutical has also explored trademark investment, creating value through intangible assets such as trademarks and brands, promoting efficiency improvement, and further expanding corporate influence; at the same time, it has continuously increased investment in new product research and development and technological transformation, and actively Declare various patents to provide strong support for brand building with technological innovation. According to incomplete statistics, Jianfeng Pharmaceutical and its subsidiaries currently have more than 120 valid trademarks, including 1 well-known trademark in China, 2 well-known trademarks in Zhejiang Province, 5 well-known trademarks in Jinhua City, and 2 overseas registered trademarks; Obtained more than 40 domestic and international patents. Trademark is an important part of intellectual property rights, in the knowledge economy, brand effect is increasingly becoming the leading force of economic development.
2020
07-31
Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base
News from our newspaper On January 19, the group company held the second meeting of the tenth board of directors and reviewed and approved the "Proposal on Foreign Investment of Subsidiary Jianfeng Pharmaceutical." On the same day, Jianfeng Pharmaceutical signed an agreement to invest in Shanghai North Carolina Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Shanghai North Carolina") by acquiring shares and increasing capital. Shanghai Beika is a high-tech enterprise in Shanghai. It has an academician expert workstation and a number of Shanghai high-tech achievements transformation projects. It has won the title of "second prize for scientific and technological progress" in Songjiang District, Shanghai, "patent pilot enterprise" and "enterprise technology center" in Songjiang District, Shanghai. The company has strong research and development capabilities and has obtained 14 patents. At present, its main business is to provide products and customized services for domestic and foreign pharmaceutical companies. The products mainly include Tinib, alkaloids, carbohydrates and other anti-tumor drug intermediates. The customized services are mainly CDMO (contract development and manufacturing) of new drugs and intermediates. Shanghai North Carolina has two wholly-owned subsidiaries, Anhui Changtai Chemical Co., Ltd. (hereinafter referred to as "Changtai Chemical") and Anhui North Carolina Pharmaceutical Co., Ltd. (hereinafter referred to as "Anhui North Carolina"). Changtai Chemical is a pesticide manufacturer designated by the Ministry of Industry and Information Technology. It was established in July 2007. It now has three chemical synthesis workshops and a pesticide preparation compounding workshop, with 10 product approvals and 13 patents. Anhui North Carolina was established in December 2016. Its business scope includes the customization, production and sales of chemical raw materials and pharmaceutical intermediates, and the wholesale and retail of chemical raw materials and products (except hazardous chemicals
2020
07-31
The company was rated as an advanced unit of the city's focus on talent and love talent.
News from our newspaper On December 11, the Talent Work Leading Group of the Jinhua Municipal Committee of the Communist Party of China commended the advanced units of Jinhua City that value talents and love talents. 36 units including Jianfeng Group won this honor. The selection of advanced units that value talents and love talents is a measure taken by the Jinhua Municipal Party Committee to further create a good atmosphere of focusing on talents and loving talents, fully respect and make good use of the first resource of talents, serve innovation to drive development, and implement the development strategy of strengthening the province with talents and innovation. The enterprises and institutions that have won this honorary title have always regarded talents as the fundamental driving force for development for a long time, regarded the investment of talents as the most effective investment, and integrated the love of talents into the unit culture. Remarkable achievements have been made in gathering talents, achieving talents, transforming and upgrading, and accelerating development. The Jinhua Municipal Party Committee requires the majority of employers to learn from advanced units, vigorously promote the trend of focusing on talents and loving talents, remove the obstacles to the talent development system and mechanism, and in accordance with the requirements of "walking in the forefront and jointly building Jinhua", in order to promote the construction of a modern metropolitan area and accelerate the construction of the province An important growth pole for high-quality development provides talent support and intellectual guarantee. (this newspaper reporter)
2020
07-31